Fredenburgh J C, Nesheim M E
Department of Medicine, Queen's University, Kingston, Ontario, Canada.
J Biol Chem. 1992 Dec 25;267(36):26150-6.
Plasminogen, the zymogen form of the fibrinolytic enzyme plasmin, is known to undergo plasmin-mediated modification in vitro. The modified form, Lys-plasminogen, is superior to the native Glu-plasminogen in fibrin binding and as a substrate for activation by tissue-type plasminogen activator (t-PA). The present study was undertaken to determine the existence and significance of the Glu- to Lys-plasminogen conversion during t-PA-mediated lysis of plasma clots in vitro. When human plasma was supplemented with exogenous Lys-plasminogen and clotted, a dose-dependent shortening of lysis time was observed. Formation of Lys-plasminogen in situ during fibrinolysis was determined using 131I-Glu-plasminogen-supplemented plasma. By the time of lysis, Lys-plasminogen had accumulated to about 20% of the initial concentration of Glu-plasminogen. Quantitation of activation of both Glu- and Lys-plasminogen as well as the conversion of Glu- to Lys-plasminogen in plasma supplemented with both 131I-Glu-plasminogen and 125I-Lys-plasminogen was accomplished by determining the flux of the isotopically labeled species along three pathways: Glu-plasminogen-->Glu-plasmin, Glu-plasminogen-->Lys-plasminogen, and Lys-plasminogen-->Lys-plasmin. After a brief lag, the Glu-plasminogen activation rate was constant until lysis was achieved, at which point activation ceased. The Lys-plasminogen activation rate also was essentially constant until lysis but was not characterized by a lag phase. The rate of conversion of Glu- to Lys-plasminogen was nonlinear and correlated directly with the rate of fibrinolysis. By the time lysis had occurred, Glu-plasminogen consumption had been distributed equally between direct activation to plasmin and conversion to Lys-plasminogen, and 45% of the plasmin which had been formed was derived from Lys-plasminogen. These results demonstrate both the formation and the subsequent activation of Lys-plasminogen during fibrinolysis. As a result of improved fibrin binding and activation of Lys-plasminogen compared to Glu-plasminogen, the formation of Lys-plasminogen within a clot constitutes a positive feedback mechanism that can further stimulate the activation of plasminogen by t-PA as fibrinolysis progresses.
纤溶酶原是纤溶酶的酶原形式,已知其在体外会发生纤溶酶介导的修饰。修饰后的形式,即赖氨酸纤溶酶原,在纤维蛋白结合以及作为组织型纤溶酶原激活剂(t-PA)激活的底物方面优于天然的谷氨酸纤溶酶原。本研究旨在确定在体外t-PA介导的血浆凝块溶解过程中谷氨酸纤溶酶原向赖氨酸纤溶酶原转化的存在及其意义。当向人血浆中补充外源性赖氨酸纤溶酶原并使其凝固时,观察到溶解时间呈剂量依赖性缩短。使用补充了131I-谷氨酸纤溶酶原的血浆来测定纤维蛋白溶解过程中原位赖氨酸纤溶酶原的形成。到溶解时,赖氨酸纤溶酶原已积累至谷氨酸纤溶酶原初始浓度的约20%。通过确定同位素标记物质沿三条途径的通量,实现了对补充了131I-谷氨酸纤溶酶原和125I-赖氨酸纤溶酶原的血浆中谷氨酸纤溶酶原和赖氨酸纤溶酶原的激活以及谷氨酸纤溶酶原向赖氨酸纤溶酶原的转化的定量:谷氨酸纤溶酶原→谷氨酸纤溶酶、谷氨酸纤溶酶原→赖氨酸纤溶酶原、赖氨酸纤溶酶原→赖氨酸纤溶酶。经过短暂的延迟后,谷氨酸纤溶酶原的激活速率在达到溶解之前保持恒定,此时激活停止。赖氨酸纤溶酶原的激活速率在溶解之前也基本恒定,但没有延迟期。谷氨酸纤溶酶原向赖氨酸纤溶酶原的转化速率是非线性的,并且与纤维蛋白溶解速率直接相关。到发生溶解时,谷氨酸纤溶酶原的消耗在直接激活为纤溶酶和转化为赖氨酸纤溶酶原之间平均分配,并且形成的纤溶酶中有45%来自赖氨酸纤溶酶原。这些结果证明了在纤维蛋白溶解过程中赖氨酸纤溶酶原的形成及其随后的激活。与谷氨酸纤溶酶原相比,由于赖氨酸纤溶酶原的纤维蛋白结合和激活得到改善,凝块内赖氨酸纤溶酶原的形成构成了一种正反馈机制,随着纤维蛋白溶解的进展,该机制可进一步刺激t-PA对纤溶酶原的激活。